Registered Nurse in Orangevale, CA Accepting Medicare

6 Registered Nurse nurses found. Showing 1 - 6

Chi Hildebrandt, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 7540 Hazel Ave, Orangevale, CA 95662 Phone: 916-412-1996    Fax: 916-988-2122

Bonnie Jean Swift, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9468 Pershing Ave, Orangevale, CA 95662 Phone: 916-988-0921

Miss Jennifer Ann Casey, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8941 Cape Windham Pl, Orangevale, CA 95662 Phone: 916-220-7976    Fax: 916-987-7447

Mabel Strasser-king, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 13140 Fair Oaks Blvd, Orangevale, CA 95662 Phone: 916-534-0089

Megan Elise Burk, RN, PHN Registered Nurse - Maternal Newborn Medicare: Not Enrolled in Medicare Practice Location: 8685 Hickory Leaf Pl, Orangevale, CA 95662 Phone: 510-432-9371

Mrs. Christina Inez Matson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6824 Escallonia Dr, Orangevale, CA 95662 Phone: 916-745-4945

News Archive

Slow walk and poor grip may predict dementia and stroke

According to U.S. researchers the speed of a person's walk may predict the likelihood of developing dementia later in life. They also told a conference that grip strength in middle-age was linked to the chance of a stroke. The scientists said more studies were needed to understand the connection.

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

Severe and necrotizing AP characterized by depletion of circulating lymphocytes

Mortality of patients with severe acute pancreatitis (SAP) approaches 30%-40%. An imbalance between the early systemic inflammatory response syndrome (SIRS), and the later compensatory counter-inflammatory response, and development of multiple organ failure (MOF) are considered to be the primary causes of morbidity and mortality in SAP. Excessive leukocyte activation (including neutrophils and monocyte-macrophage lineage) with cytokinemia play a critical role in the pathogenesis of pancreatitis and even more so, of the subsequent inflammatory response.

Pluristem Therapeutics to raise $2.7M through private placement of restricted common stock

Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.

Read more Medical News

› Verified 7 days ago